Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
We can see a decrease in the price for GlaxoSmithKline plc. Compared to yesterday it has lost -€0.308 (-1.720%).
Currently there is a rather positive sentiment for GlaxoSmithKline plc with 5 Buy predictions and 1 Sell predictions.
As a result the target price of €20.00 shows a slightly positive potential of 13.921% compared to the current price of €17.56 for GlaxoSmithKline plc.
You may not comment on this article as you either did not confirm your account yet or were blocked. If you think this is a mistake please contact us. Show more
GlaxoSmithKline plc (LSE/NYSE:GSK) today announced data from an updated analysis of the GARNET trial, which demonstrated that dostarlimab, an investigational anti-programmed death-1 (PD-1)
Join the sharewise community
Get your free sharewise account now. Registration only takes a minute and gives you access to many different things, from personal watchlists to the ability to track your own predictions and interesting games.
Information about Cookies on sharewise.com
This page uses Cookies. For proper functioning of the page Cookies are needed. You agree to using Cookies by clicking "OK".
More infos can be found in our Privacy declaration.
If you disagree this service is only available in very limited ways.
